The Future of Psychedelics

What we do now matters for mental and social health.

Michael Pollan is in large part to thank for the resurgence of psychedelics in America. His 2015 New Yorker article, “Trip Treatment,” which investigates the potential of psilocybin easing existential distress in hospice patients, triggered a national interest in the re-emerging field of clinical psychedelic studies. 

The media doesn’t just cover news bu…

This post is for paying subscribers